Back to search

Article

AstraZeneca ChAdOx1-S COVID-19 Vaccine Can Be Safely Administered in Patients with EDTA Allergy

2021-12-29

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Immediate hypersensitivity reactions to COVID-19 vaccines have been postulated to be linked to their excipients, such as polyethylene glycol (PEG) in Pfizer Comirnaty, or polysorbate 80 and ethylenediaminetetracetic acid (EDTA) in AstraZeneca ChAdOx1-S [recombinant] (Vaxzevria). These excipients are potentially found in a range of other products, including injec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
24b58f38-a80c-54db-9238-ae28fd4ddc08
DOI
10.21203/rs.3.rs-1194579/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
AstraZeneca ChAdOx1-S COVID-19 Vaccine Can Be Safely Administered in Patients with EDTA AllergyDOI 10.21203/rs.3.rs-1194579/v1
Select a neighboring publication to make it the new centre.